Literature DB >> 10351998

Necessary sample size for method comparison studies based on regression analysis.

K Linnet1.   

Abstract

BACKGROUND: In method comparison studies, it is of importance to assure that the presence of a difference of medical importance is detected. For a given difference, the necessary number of samples depends on the range of values and the analytical standard deviations of the methods involved. For typical examples, the present study evaluates the statistical power of least-squares and Deming regression analyses applied to the method comparison data.
METHODS: Theoretical calculations and simulations were used to consider the statistical power for detection of slope deviations from unity and intercept deviations from zero. For situations with proportional analytical standard deviations, weighted forms of regression analysis were evaluated.
RESULTS: In general, sample sizes of 40-100 samples conventionally used in method comparison studies often must be reconsidered. A main factor is the range of values, which should be as wide as possible for the given analyte. For a range ratio (maximum value divided by minimum value) of 2, 544 samples are required to detect one standardized slope deviation; the number of required samples decreases to 64 at a range ratio of 10 (proportional analytical error). For electrolytes having very narrow ranges of values, very large sample sizes usually are necessary. In case of proportional analytical error, application of a weighted approach is important to assure an efficient analysis; e.g., for a range ratio of 10, the weighted approach reduces the requirement of samples by >50%.
CONCLUSIONS: Estimation of the necessary sample size for a method comparison study assures a valid result; either no difference is found or the existence of a relevant difference is confirmed.

Mesh:

Substances:

Year:  1999        PMID: 10351998

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  21 in total

1.  The delusion of reducing sample size.

Authors:  Bernard Bégaud; Annie Fourrier; Nicholas Moore; Yola Moride
Journal:  Eur J Clin Pharmacol       Date:  2003-10-18       Impact factor: 2.953

Review 2.  Validation of laboratory-developed molecular assays for infectious diseases.

Authors:  Eileen M Burd
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

3.  Association of the human astrocyte elevated gene-1 promoter variants with susceptibility to hepatocellular carcinoma.

Authors:  Gholamreza Motalleb; Naghmeh Gholipour; Nader Mansour Samaei
Journal:  Med Oncol       Date:  2014-03-22       Impact factor: 3.064

4.  Fully automated chemiluminescence vs RIA aldosterone assay in primary aldosteronism work-up.

Authors:  F Pizzolo; G Salvagno; B Caruso; C Cocco; F Zorzi; C Zaltron; A Castagna; L Bertolone; F Morandini; G Lippi; O Olivieri
Journal:  J Hum Hypertens       Date:  2017-08-24       Impact factor: 3.012

5.  Cardiac and Stress Biomarkers and Chronic Kidney Disease Progression: The CRIC Study.

Authors:  Nisha Bansal; Leila Zelnick; Michael G Shlipak; Amanda Anderson; Robert Christenson; Rajat Deo; Christopher deFilippi; Harold Feldman; James Lash; Jiang He; John Kusek; Bonnie Ky; Stephen Seliger; Elsayed Z Soliman; Alan S Go
Journal:  Clin Chem       Date:  2019-10-02       Impact factor: 8.327

6.  A Real-World Setting Study: Which Glucose Meter Could Be the Best for POCT Use? An Easy and Applicable Protocol During the Hospital Routine.

Authors:  Alessio Mancini; Giampaolo Esposto; Silvana Manfrini; Silvia Rilli; Gessica Tinti; Giuseppe Carta; Laura Petrolati; Matteo Vidali; Simone Barocci
Journal:  J Diabetes Sci Technol       Date:  2018-05-22

7.  Immunoassay Analysis of Kanamycin in Serum Using the Tobramycin Kit.

Authors:  J A Dijkstra; A J Voerman; B Greijdanus; D J Touw; J W C Alffenaar
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

8.  Plasma glucose measurement with the Yellow Springs Glucose 2300 STAT and the Olympus AU640.

Authors:  P J Twomey
Journal:  J Clin Pathol       Date:  2004-07       Impact factor: 3.411

9.  Blood pressure measurement during cesarean delivery: Evaluation of a beat-to-beat noninvasive device (NexfinTM).

Authors:  Mathieu Bobet; Jona Joachim; Etienne Gayat; Agnès Bonnet; Kerstin Sievert; Carole Barnichon; Marc Fischler; Morgan Le Guen
Journal:  Medicine (Baltimore)       Date:  2021-06-04       Impact factor: 1.817

10.  Upper Reference Limits for High-Sensitivity Cardiac Troponin T and N-Terminal Fragment of the Prohormone Brain Natriuretic Peptide in Patients With CKD.

Authors:  Nisha Bansal; Leila R Zelnick; Christie M Ballantyne; Paulo H M Chaves; Robert H Christenson; Josef Coresh; Christopher R deFilippi; James A de Lemos; Lori B Daniels; Alan S Go; Jiang He; S Susan Hedayati; Kunihiro Matsushita; Vijay Nambi; Michael G Shlipak; Jonathan J Taliercio; Stephen L Seliger
Journal:  Am J Kidney Dis       Date:  2021-07-19       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.